Clinical diagnosis and treatment for age-related macular degeneration: a brief analysis of the guidelines

Abstract

Age-related macular degeneration (AMD) is a common cause of blindness among people over 65 in developed countries. With the rapidity of population aging process, the prevalence of AMD will be further increased. The application of anti-vascular endothelial factor growth medicine in ophthalmology has made great progress in the therapeutic effect and prognosis of wet AMD. In this context, many countries and regions have successively formulated guidelines for the AMD clinical diagnosis and treatment, especially the United States, Europe and Australia. Through the analysis of AMD clinical guidelines of American Academy of Ophthalmology (AAO) in 2015, and by comparing it with AMD analysis and treatment guidelines of European Society of Retina Specialists (EURETINA) in 2014, this paper provides an accurate, effective and comprehensive diagnosis strategy and lays a foundation for providing AMD patients with quality diagnosis and treatment plans. Key words: Macular degeneration/DI/TH; Guideline